NDC 67296-2102

Tizanidine 4 mg tablet

On the label: RedPharm Drug. Inc.. It's repackaged: RedPharm Drug. Inc. rebottles it from Dr.Reddy's Laboratories Ltd.'s NDC 55111-180.

Where the pills inside were made

Factory	Where	Role	Last FDA inspection
Dr. Reddy's Laboratories Limited	Medchal-Malkajgiri, India	Makes it and tests it	Problems found, fixed voluntarilyOct 27, 2023 · 8 inspections
Dr. Reddy's Laboratories Limited	Srikakulam, India	Makes it and tests it	Problems found, fixed voluntarilyMay 20, 2022 · 5 inspections

Jan 2, 2024 · Class II · Dr. Reddy's Laboratories, Inc.
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Lots: Lot #: T2304007, Exp 7/31/2026
Jun 21, 2023 · Class II · Dr Reddy's Laboratories Limited
Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Lots: Lot: T2100585, T2100586, T2100587, Exp 12/2023
Jul 19, 2021 · Class II · Dr. Reddy's Laboratories, Inc.
Failed Tablet/Capsule Specification: Some tablets are shaved
Lots: Lot #: T2000471, exp date 09/2023
Sep 4, 2018 · Class II · Dr. Reddy's Laboratories, Inc.
Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .
Lots: Lot #: T800304, Exp. 03/2021
Mar 19, 2013 · Class III · Dr. Reddy'S Laboratories
Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.
Lots: Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Generic drug: Tizanidine: every company that makes it
Form: tablet
Strength: 4 mg
Approval: ANDA ANDA076286
On the market since: Jul 3, 2002
Package NDCs: 67296-2102-2
Official label: DailyMed (National Library of Medicine), updated Jul 25, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?